Strata Skin Sciences Inc   (SSKN)
Other Ticker:  
Price: $0.5000 $0.00 -0.200%
Day's High: $0.54 Week Perf: -2.31 %
Day's Low: $ 0.50 30 Day Perf: -4.76 %
Volume (M): 3 52 Wk High: $ 1.15
Volume (M$): $ 2 52 Wk Avg: $0.74
Open: $0.53 52 Wk Low: $0.26

 Market Capitalization (Millions $) 17
 Shares Outstanding (Millions) 35
 Employees -
 Revenues (TTM) (Millions $) 33
 Net Income (TTM) (Millions $) -7
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 7

Strata Skin Sciences Inc
Strata Skin Sciences Inc is a medical technology company primarily focused on the dermatology market. The company develops, manufactures, and markets innovative devices for treating various skin conditions and diseases. Their flagship product is the XTRAC laser system, which is used to treat psoriasis, vitiligo, and other skin disorders.

The XTRAC laser system uses a targeted phototherapy technology that delivers concentrated ultraviolet light to affected areas of the skin, providing a safe and effective treatment option. The company also provides training, support, and service to healthcare professionals who use their devices.

In addition to the XTRAC laser system, Strata Skin Sciences Inc offers other dermatological devices, such as the Nordlys device for vascular and pigmented lesions, and the STRATAPEN microneedling device for skin rejuvenation and scar treatment.

The company has a global presence and serves customers in over 70 countries. They are committed to continuous innovation and investing in research and development to expand their product portfolio and improve patient outcomes.

   Company Address: 5 Walnut Grove Drive Horsham 19044 PA
   Company Phone Number: 619-3200   Stock Exchange / Ticker: NASDAQ SSKN
   SSKN is expected to report next financial results on March 30, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Financing Agreement

Strata Skin Sciences Inc Enhances Financial Flexibility with Successful Amendment to Credit Agreement

Published Mon, Feb 26 2024 9:01 PM UTC

Strata Skin Sciences Inc recently announced a successful amendment to its credit agreement with MidCap Financial, which amends certain financial covenants to enhance liquidity and financial flexibility. This move ensures alignment with the company's current and future business operations.
Despite a net increase in borrowings by -19.05% in the third quarter of 2...


Strata Skin Sciences fortifies its Global Reach: Expands Distribution Agreement with Kosmo Meditech

Published Fri, Dec 29 2023 1:00 PM UTC

Strata Skin Sciences, a leading medical technology company targeting dermatology and plastic surgery, has recently announced the expansion of its distribution agreement with Kosmo Meditech, an Asian-based medical technology company. This strategic step significantly bolsters the relationship between the two companies, potentially enabling Strata Skin Sciences to penetrate de...

Strata Skin Sciences Inc

Struggles on Shaky Sales Plunge Company into Losses Throughout the Fiscal Interval Closing Sep 30 2023

Strata Skin Sciences Inc, a leading healthcare company, recently reported its earnings for the third quarter of 2023. The company experienced a loss of $0.03 per share, which was the same as the previous year. However, there was an improvement in earnings per share compared to the previous reporting period, where it was $0.09 per share.
One notable aspect of the earnings report was the decline in revenue. The company's revenue decreased by 15.5% from $9.41 million to $7.95 million compared to the same period last year. However, there was a sequential increase in revenue by 8.691% from the previous quarter's revenue of $7.32 million.


Strata Skin Sciences Grants Inducement Awards to Newly Appointed Leadership, Impacting Stock Performance

Published Tue, Oct 31 2023 8:02 PM UTC

Strata Skin Sciences, Inc. Grants Inducement Awards to Dr. Dolev Rafaeli and Influences Stock Performance
In a recent press release, Strata Skin Sciences, Inc. announced that it has granted equity-based awards to Dr. Dolev Rafaeli under Nasdaq Listing Rule 5635(c)(4). These awards were given as an inducement for Dr. Rafaeli to enter into an employment agreement with the...

Strata Skin Sciences Inc

Strata Skin Sciences Inc. Battles Adversities, Sees Decline in Performance Amidst Challenging Fiscal Period

Strata Skin Sciences Inc, a prominent player in the Medical Equipment & Supplies industry, recently released its financial results for the period ending June 30, 2023. These results indicate a disappointing performance for the company, with several key metrics showing a decline compared to the previous year.
One of the significant highlights from the financial report is the increase in the shortfall per share. The company witnessed a shortfall of $-0.09 per share, which is higher than both the previous year's figure of $-0.05 per share and the preceding financial reporting period's figure of $-0.08 per share. This indicates a deterioration in the company's financial health, as it struggles to generate profits.


Strata Skin Sciences Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com